Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewSNDX-5613 is a potent inhibitor of menin-MLL1 protein-protein interaction (Ki = 0.149 nM; IC50 = 10-20 nM). Induces promising antileukaemic activity leading to deep and sustained remission in patients with highly refractory acute leukaemia with KMT2Ar or NPM1 mutation.
| M. Wt | 630.82 |
| Formula | C32H47FN6O4S |
| Storage | Store at -20°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 2169919-21-3 |
| PubChem ID | 132212657 |
| InChI Key | FRVSRBKUQZKTOW-YOCNBXQISA-N |
| Smiles | CC(N(C(C1=CC(F)=CC=C1OC2=C(N=CN=C2)N3CC4(C3)CCN(CC4)C[C@@H]5CC[C@H](CC5)NS(CC)(=O)=O)=O)CC)C |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 31.54 | 50 | |
| ethanol | 12.62 | 20 |
The following data is based on the product molecular weight 630.82. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 3.17 mL | 15.85 mL | 31.7 mL |
| 2.5 mM | 0.63 mL | 3.17 mL | 6.34 mL |
| 5 mM | 0.32 mL | 1.59 mL | 3.17 mL |
| 25 mM | 0.06 mL | 0.32 mL | 0.63 mL |
References are publications that support the biological activity of the product.
Fiskus et al (2023) Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. Blood Cancer J. 13 PMID: 37055414
Issa et al (2023) The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature 615 920 PMID: 36922593
Perner et al (2023) MEN1 mutations mediate clinical resistance to menin inhibition. 615 913 PMID: 36922589
If you know of a relevant reference for SNDX-5613, please let us know.
Keywords: SNDX-5613, SNDX-5613 supplier, Revumenib, SNDX-5613, SNDC, 5613, potent, inhibitor, inhibits, protein, interaction, PPI, Menin, MEN1, MLL1, lysine, methyltransferase, refractory, acute, leukaemia, KMT2A, NPM1, mutation, Other, Lysine, Methyltransferases, 8907, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for SNDX-5613. Do you know of a great paper that uses SNDX-5613 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review SNDX-5613 and earn rewards!
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image